This 2nd position paper of our 2023 Medical Series proposes 5 recommendations and several tools to develop High-Performance Strategic Medical Plans.
News
Based on the analysis of the most recent data and trends (gathered in The Global Pharma Market...
This document shares essential recommendations to help pharma companies develop business forecasting, based on academic methods and...
The quality of Medical Brand Plans is often sub-optimal due to aweak building process, a lack of...